Hypertriglyceridemia in the Genomic Era: A New Paradigm
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemia (HTG) is a highly prevalent condition that is associated with increased cardiovascular disease risk. HTG may arise as a result of defective metabolism of triglyceride-rich lipoproteins and their remnants, ie, impaired clearance, or increased production, or both. Current categorization of HTG segregates primary and secondary cases, implying genetic and nongenetic causes for each category. Many common and rare variants of the genes encoding factors involved in these pathways have been identified. Although monogenic forms of HTG do occur, most cases are polygenic and often coexist with nongenetic conditions. Cumulative, multiple genetic variants can increase the risks for HTG, whereas environmental and lifestyle factors can force expression of a dyslipidemic phenotype in a genetically susceptible person. HTG states are therefore best viewed as a complex phenotype resulting from the interaction of cumulated multiple susceptibility genes and environmental stressors. In view of the heterogeneity of the HTG states, the absence of a unifying metabolic or genetic abnormality, overlap with the metabolic syndrome and other features of insulin resistance, and evidence in some patients that accumulation of numerous small-effect genetic variants determines whether an individual is susceptible to HTG only or to HTG plus elevated low-density lipoprotein cholesterol, we propose that the diagnosis of primary HTG and further delineation of familial combined hyperlipidemia from familial HTG is neither feasible nor clinically relevant at the present time. The hope is that with greater understanding of genetic and environmental causes and their interaction, therapy can be intelligently targeted in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mendelian randomization studies also suggest that the association between plasma TGs and the risk of CHD may be causal; however, this evidence must be interpreted with caution because nearly all variants associated with TGs are also associated with HDL-C, LDL-C, or Lp(a) [56-59].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [57]
Citations
Cites
1 retracted
Doolittle, M. H., Neher, S. B., Ben-Zeev, O., Ling-liao, J., Gallagher, C. M., Hosseini, M., Yin, F., Wong, H., Walter, P., & Péterfy, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049395 · Cited by 29
RetractedThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
Cited by
Items 101–152 of 152
El concepto de hipertrigliceridemia severa y sus implicaciones para la práctica clínica
Pintó, X., & Esteve-Luque, V. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.08.001 · Cited by 6
The state of lipid exchange in persons living in the territory of environmental illusion
Валерьевна, К. И., & Lysenko, A. A. (2023) · Hygiene and Sanitation · doi:10.47470/0016-9900-2023-102-9-896-901 · Cited by 6
Xu, K., Chen, P., Su, Y., Chen, Y., Song, X., Yu, B., & Wang, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100850 · Cited by 4
Ain, Q. U., Cevc, M., Marusic, T., Šikonja, J., Sadiq, F., Šuštar, U., Mlinarič, M., Kovač, J., Batool, H., Khan, M. I., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1387419 · Cited by 6
Bunn, T. L., Langner, K., Foster, S. F., Hayward, D. A., Howard, G., Paltrinieri, S., Giordano, A., & Rossi, G. (2023) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/10406387231217505 · Cited by 4
The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
Utkina, E. A., Afanasieva, O. I., & Pokrovsky, S. N. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-5-82-89 · Cited by 5
Lipaemic blood: alcohol-induced acute hypertriglyceridaemia
Ali, A. A., Fasen, M., Ng, K., & Shelley, P. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243167 · Cited by 4
A foray into Understanding the Next Billion Search Users
Gupta, N., & Rosé, C. P. (2009) · Cited by 3
Tate, N. M., Yamkate, P., Xenoulis, P. G., Steiner, J. M., Behling‐Kelly, E. L., Rendahl, A., Wu, Y., & Furrow, E. (2024) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.17010 · Cited by 3
Genetische Erkrankungen des Lipidstoffwechsels: Schwerpunkt familiäre Hypercholesterinämie
März, W., Beil, F.-U., & Dieplinger, H. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1516-2541 · Cited by 3
Bedoya, C., Thomas, R., Bjarvin, A., Ji, W., Samara, H., Tai, J., Green, L., Frost, P. H., Malloy, M. J., Pullinger, C. R., et al. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.10.004 · Cited by 2
Sequence Analysis of Six Candidate Genes in Miniature Schnauzers with Primary Hypertriglyceridemia
Tate, N. M., Underwood, M., Thomas‐Hollands, A., Minor, K. M., Cullen, J. N., Friedenberg, S. G., Mickelson, J. R., Xenoulis, P. G., Steiner, J. M., & Furrow, E. (2024) · Genes · doi:10.3390/genes15020193 · Cited by 3
Baker, L. A., Minor, K. M., Tate, N. M., & Furrow, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313343 · Cited by 3
Dyslipidaemia in Liver Diseases
Hlušička, J., & Žák, A. (2024) · Folia Biologica · doi:10.14712/fb2024070050239 · Cited by 2
Zhou, M., Sun, T., Yan, Y., Jing, M., Gao, Y., Jiang, B., Wang, Q., Ma, S., Xuan, Q., & Zhao, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06171-5 · Cited by 2
Skoczyńska, A., Wawrzynowicz‐Syczewska, M., Barlik-Rysa, M., Danik, A., Różański, J., Filipiak, K. J., & Cybulska, B. (2020) · Folia Cardiologica · doi:10.5603/fc.2020.0001 · Cited by 1
Estudio sobre la asociación de hipertrigliceridemia con los estados hipertensivos del embarazo
Serrano-Berrones, M. Á., & Barragán-Padilla, S. B. (2019) · Gaceta Médica de México · doi:10.24875/gmm.19005137 · Cited by 2
Molina, D. I., Villar-Moya, R., Villar-Henríquez, M., & Murillo-Aranguren, M. C. (2022) · Revista Colombiana de Cardiología · doi:10.24875/rccar.m21000053 · Cited by 7
HYPERTRIGLYCERIDEMIA AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASES
NURIEVA, L. M., KIM, Z. F., GALYVICH, A. S., & Sadykova, D. I. (2023) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2023.16(4).104-110 · Cited by 2
Lipids, Lipoproteins, and Cardiovascular Outcomes
Sakers, A. P., Mszar, R., & Soffer, D. E. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_9 · Cited by 1
Is it time to break the fast?—a paradigm shift in clinical lipidology
Cabezas, M. C., Burggraaf, B., & Klop, B. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.09.42 · Cited by 2
Investigated treatments for lipoprotein lipase deficiency and related metabolic disorders
Lee, J.-H., & Hegele, R. A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1311784 · Cited by 1
Self-citationCORONARY ARTERY DISEASE RISK AND LIPIDOMIC PROFILES IN FAMILIAL HYPERLIPIDEMIAS
Rämö, J. T., Ripatti, P., Tabassum, R., Söderlund, S., Matikainen, N., Gerl, M. J., Klose, C. D., Surma, M. A., Stitziel, N. O., Havulinna, A. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(19)32376-9 · Cited by 2
Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management
Cupido, A. J., Stoekenbroek, R. M., & Kastelein, J. J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_21 · Cited by 1
Frequencies of variants in genes associated with dyslipidemias identified in Costa Rican genomes
Valverde-Hernández, J. C., Flores-Cruz, A., Chavarría‐Soley, G., de la Fuente, S. S., & Campos-Sánchez, R. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1114774 · Cited by 2
Genetics and Valve Calcification ∗
Brown, W. V. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.048 · Cited by 1
Microduplication of 10q26.3 in a Chinese hypertriglyceridemia patient
Li, J., Chen, Y., Fan, L., Jin, J., Guo, S., & Xiang, R. (2017) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.11.002 · Cited by 2
Титов, В. Н., Ta, R., Kaminnaya, V. I., & Alchinova, I. B. (2019) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2019-64-1-4-13 · Cited by 2
Current Concepts in Management of Lipid Abnormalities in Patients With Coronary Artery Disease
Mahajan, K., & Chandra, K. S. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620943020 · Cited by 2
Camila Jure, B., Lucy Sapiain, P., & Susana González, F. (2020) · Revista médica de Chile · doi:10.4067/s0034-98872020000901362 · Cited by 1
Molecular Genetics of Hypertriglyceridaemia
Dron, J. S., & Hegele, R. A. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0026710 · Cited by 2
Self-citationClassification of Hyperlipidemias and Dyslipidemias
Núñez-Cortes, J. E. M., & Pérez, J. J. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65816-6 · Cited by 1
Vieira, D. A. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2017.tde-05012017-113106
Genetic and Epigenetic Regulations of Post-prandial Lipemia
Xu, H. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0146-9
The concept of severe hypertriglyceridaemia and its implications for clinical practice
Pintó, X., & Esteve-Luque, V. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2018.08.004
Lipidsenkung jenseits des LDL-Cholesterins
Katzmann, J. L., & Laufs, U. (2021) · Kardiologie up2date · doi:10.1055/a-0897-2742
Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management
Cupido, A. J., Stoekenbroek, R. M., & Kastelein, J. J. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_23
Clinical Effects of Inadvertent Increased Lipid Infusion in Neonates
Hulgan, C. M., Snow, T., & Check, J. F. (2022) · Advances in Neonatal Care · doi:10.1097/anc.0000000000000986
Primär genetische Dyslipoproteinämien und Atheroskleroserisiko
Schwab, K. O., & Doerfer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-63320-5_3
Arrobas-Velilla, T., Ariza, M. J., Rico, M. Á., & Valdivielso, P. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2024.03.004
Obregón, O., Aure, G., Amaiz, M. L., Castro, J., & Brito, S. (2024) · Revista Científica CMDLT · doi:10.55361/cmdlt.v17i1.276 · Cited by 1
Arrobas-Velilla, T., Ariza, M. J., Rico, M. Á., & Valdivielso, P. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2024.09.005
Strategies to Overcome Metabolic Syndrome and Related Diseases
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5556-9
Cruz-Bautista, I., Huerta‐Chagoya, A., Moreno-Macías, H., Rodríguez-Guillén, R., Ordóñez-Sánchez, M. L., Segura-Kato, Y., Mehta, R., Almeda-Valdés, P., Gómez-Munguía, L., Chávez, X. R.-D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14037373
Cruz-Bautista, I., Huerta‐Chagoya, A., Moreno-Macías, H., Rodríguez-Guillén, R., Ordóñez-Sánchez, M. L., Segura-Kato, Y., Mehta, R., Almeda-Valdés, P., Gómez-Munguía, L., Chávez, X. R.-D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14037370
Li, X.-Y., Pu, N., Chen, W.-W., Shi, X.-L., Zhang, G.-F., Ke, L., Ye, B., Tong, Z.-H., Wang, Y.-H., George, L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12096705
Groß, S., Ruser, A., & Siebert, U. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1898173
Shomin, A. V., Serezhina, E. K., & Обрезан, А. Г. (2026) · Cardiosomatics · doi:10.17816/cs685972
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy
Aslesh, T., & Yokota, T. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5476-7_5
Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management
Qi, S., Chen, W., Chen, K., Yang, S., Wang, S., Ni, T., Xu, D., Mao, E., Chen, E., & Chen, Y. (2026) · MedComm · doi:10.1002/mco2.70956
Metadata
- Authors
- Lewis, G. F., Xiao, C., & Hegele, R. A.
- Affiliations
- University of Toronto (CA)
- Western University (CA)
- Corresponding author
- Lewis, Gary F.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-02-01
- Volume
- 36
- Issue
- 1
- Pages
- 131-147
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2142850613
- Cited by
- 152
- References
- 113
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 14 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 22 · 2019: 17 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 8
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Genome Canada
- Canadian Institutes of Health Research (79533, MOP‑79533), MOP13430, MOP-43839)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hypertriglyceridemia, triglyceride-rich lipoproteins, remnant lipoproteins, genetic susceptibility, polygenic inheritance, familial combined hyperlipidemia, familial hypertriglyceridemia, metabolic syndrome, insulin resistance, LDL cholesterol, gene-environment interaction, cardiovascular risk, dyslipidemia
- MeSH terms
- Alcohol Drinking, Diabetes Mellitus, Type 2, Environment, Female, Humans, Insulin Resistance, Life Style, Lipoproteins, Male, Metabolic Clearance Rate, Middle Aged, Nephrotic Syndrome, Phenotype, Pregnancy, Pregnancy Complications, Risk Factors, Triglycerides, Genetic Variation, Hypertriglyceridemia, Genetic Predisposition to Disease, Metabolic Syndrome, Atherosclerosis, Renal Insufficiency, Chronic, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.